A Deadline is coming up on March 19, 2018 in the lawsuit for investors in TESARO Inc (NASDAQ:TSRO) and NASDAQ:TSRO stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 03/13/2018 --A deadline is coming up on March 19, 2018 in the lawsuit filed for certain investors of TESARO Inc (NASDAQ:TSRO) over alleged securities laws violations by TESARO Inc.

Investors who purchased shares of TESARO Inc (NASDAQ:TSRO) have certain options and there are strict and short deadlines running. Deadline: March 19, 2018. NASDAQ:TSRO stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges on behalf of purchasers of TESARO Inc (NASDAQ:TSRO) common shares between March 14, 2016 and January 12, 2018, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between March 14, 2016 and January 12, 2018, the Defendants made false and/or misleading statements and/or failed to disclose that substantial undisclosed health risks, including anaphylaxis and anaphylactic shock, were associated with Tesaro's intravenous formulation of Varubi, and that as a result of the foregoing, Tesaro's shares traded at artificially inflated prices between March 14, 2016 and January 12, 2018, and class members suffered significant losses and damages.

Those who purchased shares of TESARO Inc (NASDAQ:TSRO) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com